课题基金 / 基金详情

Alpha Synuclein, cellular dysfunction and Parkinson disease

Alpha Synuclein, cellular dysfunction and Parkinson disease
α 突触核蛋白、细胞功能障碍和帕金森病
批准号:
8156800
负责人:
Mark Cookson
金额:
$5.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Mark Cookson的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alpha-synuclein was the first gene identified for Parkinsons disease and has been associated with a number of detrimental effects in cells and in animal models. The protein itself is expressed at high levels in neurons where it is associated with membranous structures including presynaptic vesicles. One difficult question is why a-synuclein would, at least in some circumstances, lead to the death of neurons. One possibility is that aspects of neurotransmitter metabolism are important and we have previously shown that some groups of neurons are more susceptible than others to a-synuclein toxicity. Dopaminergic cells are especially vulnerable and we have recently reported that increasing expression of a-synuclein makes human neuroblastoma cells more susceptible to dopamine associated toxicity. Ongoing work in the lab is aimed at understanding the normal and toxic functions of a-synuclein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Alpha Synuclein, cellular dysfunction and Parkinson disease
  • 批准号:
    8552517
  • 项目类别:
  • 资助金额:
    $17.49万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
Gene expression in the human brain
  • 批准号:
    8736661
  • 项目类别:
  • 资助金额:
    $25.35万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
DJ-1 function and oxidative stress
  • 批准号:
    8552528
  • 项目类别:
  • 资助金额:
    $34.98万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
Leucine rich repeat kinase 2 and dominantly inherited Parkinson disease
  • 批准号:
    8552524
  • 项目类别:
  • 资助金额:
    $64.96万
  • 财政年份:
    --
  • 负责人:
    Mark Cookson
  • 依托单位:
海外基金